Global Procalcitonin Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030

Global Procalcitonin Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030


Summary

Procalcitonin (PCT), CAS 56645-65-9, is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli

According to APO Research, The global Procalcitonin market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

North American market for Procalcitonin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Procalcitonin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Procalcitonin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Procalcitonin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Procalcitonin include Thermo Fisher, Roche Diagnostics, bioMerieux, HyTest, BBI Solutions, ProSpec, Wondfo, Ningbo Medicalsystem Biotechnology and Wuhan Easy Diagnosis Biomedicine, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Procalcitonin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Procalcitonin, also provides the sales of main regions and countries. Of the upcoming market potential for Procalcitonin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Procalcitonin sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Procalcitonin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Procalcitonin sales, projected growth trends, production technology, application and end-user industry.

Procalcitonin segment by Company

Thermo Fisher
Roche Diagnostics
bioMerieux
HyTest
BBI Solutions
ProSpec
Wondfo
Ningbo Medicalsystem Biotechnology
Wuhan Easy Diagnosis Biomedicine
Snibe
Vazyme Biotech
Getein Biotech
Hotgen Biotech
Lumigenex
Nanjing Norman Biological Technology
Kitgen
Beijing KeyGen
Beijing Apis
Procalcitonin segment by Type

Procalcitonin Antigen
Procalcitonin Antibody
Procalcitonin segment by Application

Medical Industry
Scientific Research
Veterinarian
Procalcitonin segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Procalcitonin status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Procalcitonin market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Procalcitonin significant trends, drivers, influence factors in global and regions.
6. To analyze Procalcitonin competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Procalcitonin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Procalcitonin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Procalcitonin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Procalcitonin market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Procalcitonin industry.
Chapter 3: Detailed analysis of Procalcitonin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Procalcitonin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Procalcitonin in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Procalcitonin Sales Value (2019-2030)
1.2.2 Global Procalcitonin Sales Volume (2019-2030)
1.2.3 Global Procalcitonin Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Procalcitonin Market Dynamics
2.1 Procalcitonin Industry Trends
2.2 Procalcitonin Industry Drivers
2.3 Procalcitonin Industry Opportunities and Challenges
2.4 Procalcitonin Industry Restraints
3 Procalcitonin Market by Company
3.1 Global Procalcitonin Company Revenue Ranking in 2023
3.2 Global Procalcitonin Revenue by Company (2019-2024)
3.3 Global Procalcitonin Sales Volume by Company (2019-2024)
3.4 Global Procalcitonin Average Price by Company (2019-2024)
3.5 Global Procalcitonin Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Procalcitonin Company Manufacturing Base & Headquarters
3.7 Global Procalcitonin Company, Product Type & Application
3.8 Global Procalcitonin Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Procalcitonin Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Procalcitonin Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 Procalcitonin Market by Type
4.1 Procalcitonin Type Introduction
4.1.1 Procalcitonin Antigen
4.1.2 Procalcitonin Antibody
4.2 Global Procalcitonin Sales Volume by Type
4.2.1 Global Procalcitonin Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Procalcitonin Sales Volume by Type (2019-2030)
4.2.3 Global Procalcitonin Sales Volume Share by Type (2019-2030)
4.3 Global Procalcitonin Sales Value by Type
4.3.1 Global Procalcitonin Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Procalcitonin Sales Value by Type (2019-2030)
4.3.3 Global Procalcitonin Sales Value Share by Type (2019-2030)
5 Procalcitonin Market by Application
5.1 Procalcitonin Application Introduction
5.1.1 Medical Industry
5.1.2 Scientific Research
5.1.3 Veterinarian
5.2 Global Procalcitonin Sales Volume by Application
5.2.1 Global Procalcitonin Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Procalcitonin Sales Volume by Application (2019-2030)
5.2.3 Global Procalcitonin Sales Volume Share by Application (2019-2030)
5.3 Global Procalcitonin Sales Value by Application
5.3.1 Global Procalcitonin Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Procalcitonin Sales Value by Application (2019-2030)
5.3.3 Global Procalcitonin Sales Value Share by Application (2019-2030)
6 Procalcitonin Market by Region
6.1 Global Procalcitonin Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Procalcitonin Sales by Region (2019-2030)
6.2.1 Global Procalcitonin Sales by Region: 2019-2024
6.2.2 Global Procalcitonin Sales by Region (2025-2030)
6.3 Global Procalcitonin Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Procalcitonin Sales Value by Region (2019-2030)
6.4.1 Global Procalcitonin Sales Value by Region: 2019-2024
6.4.2 Global Procalcitonin Sales Value by Region (2025-2030)
6.5 Global Procalcitonin Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Procalcitonin Sales Value (2019-2030)
6.6.2 North America Procalcitonin Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Procalcitonin Sales Value (2019-2030)
6.7.2 Europe Procalcitonin Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Procalcitonin Sales Value (2019-2030)
6.8.2 Asia-Pacific Procalcitonin Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Procalcitonin Sales Value (2019-2030)
6.9.2 Latin America Procalcitonin Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Procalcitonin Sales Value (2019-2030)
6.10.2 Middle East & Africa Procalcitonin Sales Value Share by Country, 2023 VS 2030
7 Procalcitonin Market by Country
7.1 Global Procalcitonin Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Procalcitonin Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Procalcitonin Sales by Country (2019-2030)
7.3.1 Global Procalcitonin Sales by Country (2019-2024)
7.3.2 Global Procalcitonin Sales by Country (2025-2030)
7.4 Global Procalcitonin Sales Value by Country (2019-2030)
7.4.1 Global Procalcitonin Sales Value by Country (2019-2024)
7.4.2 Global Procalcitonin Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Procalcitonin Sales Value Growth Rate (2019-2030)
7.5.2 Global Procalcitonin Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Procalcitonin Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Procalcitonin Sales Value Growth Rate (2019-2030)
7.6.2 Global Procalcitonin Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Procalcitonin Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Procalcitonin Sales Value Growth Rate (2019-2030)
7.7.2 Global Procalcitonin Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Procalcitonin Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Procalcitonin Sales Value Growth Rate (2019-2030)
7.8.2 Global Procalcitonin Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Procalcitonin Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Procalcitonin Sales Value Growth Rate (2019-2030)
7.9.2 Global Procalcitonin Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Procalcitonin Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Procalcitonin Sales Value Growth Rate (2019-2030)
7.10.2 Global Procalcitonin Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Procalcitonin Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Procalcitonin Sales Value Growth Rate (2019-2030)
7.11.2 Global Procalcitonin Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Procalcitonin Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Procalcitonin Sales Value Growth Rate (2019-2030)
7.12.2 Global Procalcitonin Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Procalcitonin Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Procalcitonin Sales Value Growth Rate (2019-2030)
7.13.2 Global Procalcitonin Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Procalcitonin Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Procalcitonin Sales Value Growth Rate (2019-2030)
7.14.2 Global Procalcitonin Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Procalcitonin Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Procalcitonin Sales Value Growth Rate (2019-2030)
7.15.2 Global Procalcitonin Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Procalcitonin Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Procalcitonin Sales Value Growth Rate (2019-2030)
7.16.2 Global Procalcitonin Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Procalcitonin Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Procalcitonin Sales Value Growth Rate (2019-2030)
7.17.2 Global Procalcitonin Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Procalcitonin Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Procalcitonin Sales Value Growth Rate (2019-2030)
7.18.2 Global Procalcitonin Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Procalcitonin Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Procalcitonin Sales Value Growth Rate (2019-2030)
7.19.2 Global Procalcitonin Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Procalcitonin Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Procalcitonin Sales Value Growth Rate (2019-2030)
7.20.2 Global Procalcitonin Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Procalcitonin Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Procalcitonin Sales Value Growth Rate (2019-2030)
7.21.2 Global Procalcitonin Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Procalcitonin Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Procalcitonin Sales Value Growth Rate (2019-2030)
7.22.2 Global Procalcitonin Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Procalcitonin Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Procalcitonin Sales Value Growth Rate (2019-2030)
7.23.2 Global Procalcitonin Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Procalcitonin Sales Value Share by Application, 2023 VS 2030
8 Company Profiles
8.1 Thermo Fisher
8.1.1 Thermo Fisher Comapny Information
8.1.2 Thermo Fisher Business Overview
8.1.3 Thermo Fisher Procalcitonin Sales, Value and Gross Margin (2019-2024)
8.1.4 Thermo Fisher Procalcitonin Product Portfolio
8.1.5 Thermo Fisher Recent Developments
8.2 Roche Diagnostics
8.2.1 Roche Diagnostics Comapny Information
8.2.2 Roche Diagnostics Business Overview
8.2.3 Roche Diagnostics Procalcitonin Sales, Value and Gross Margin (2019-2024)
8.2.4 Roche Diagnostics Procalcitonin Product Portfolio
8.2.5 Roche Diagnostics Recent Developments
8.3 bioMerieux
8.3.1 bioMerieux Comapny Information
8.3.2 bioMerieux Business Overview
8.3.3 bioMerieux Procalcitonin Sales, Value and Gross Margin (2019-2024)
8.3.4 bioMerieux Procalcitonin Product Portfolio
8.3.5 bioMerieux Recent Developments
8.4 HyTest
8.4.1 HyTest Comapny Information
8.4.2 HyTest Business Overview
8.4.3 HyTest Procalcitonin Sales, Value and Gross Margin (2019-2024)
8.4.4 HyTest Procalcitonin Product Portfolio
8.4.5 HyTest Recent Developments
8.5 BBI Solutions
8.5.1 BBI Solutions Comapny Information
8.5.2 BBI Solutions Business Overview
8.5.3 BBI Solutions Procalcitonin Sales, Value and Gross Margin (2019-2024)
8.5.4 BBI Solutions Procalcitonin Product Portfolio
8.5.5 BBI Solutions Recent Developments
8.6 ProSpec
8.6.1 ProSpec Comapny Information
8.6.2 ProSpec Business Overview
8.6.3 ProSpec Procalcitonin Sales, Value and Gross Margin (2019-2024)
8.6.4 ProSpec Procalcitonin Product Portfolio
8.6.5 ProSpec Recent Developments
8.7 Wondfo
8.7.1 Wondfo Comapny Information
8.7.2 Wondfo Business Overview
8.7.3 Wondfo Procalcitonin Sales, Value and Gross Margin (2019-2024)
8.7.4 Wondfo Procalcitonin Product Portfolio
8.7.5 Wondfo Recent Developments
8.8 Ningbo Medicalsystem Biotechnology
8.8.1 Ningbo Medicalsystem Biotechnology Comapny Information
8.8.2 Ningbo Medicalsystem Biotechnology Business Overview
8.8.3 Ningbo Medicalsystem Biotechnology Procalcitonin Sales, Value and Gross Margin (2019-2024)
8.8.4 Ningbo Medicalsystem Biotechnology Procalcitonin Product Portfolio
8.8.5 Ningbo Medicalsystem Biotechnology Recent Developments
8.9 Wuhan Easy Diagnosis Biomedicine
8.9.1 Wuhan Easy Diagnosis Biomedicine Comapny Information
8.9.2 Wuhan Easy Diagnosis Biomedicine Business Overview
8.9.3 Wuhan Easy Diagnosis Biomedicine Procalcitonin Sales, Value and Gross Margin (2019-2024)
8.9.4 Wuhan Easy Diagnosis Biomedicine Procalcitonin Product Portfolio
8.9.5 Wuhan Easy Diagnosis Biomedicine Recent Developments
8.10 Snibe
8.10.1 Snibe Comapny Information
8.10.2 Snibe Business Overview
8.10.3 Snibe Procalcitonin Sales, Value and Gross Margin (2019-2024)
8.10.4 Snibe Procalcitonin Product Portfolio
8.10.5 Snibe Recent Developments
8.11 Vazyme Biotech
8.11.1 Vazyme Biotech Comapny Information
8.11.2 Vazyme Biotech Business Overview
8.11.3 Vazyme Biotech Procalcitonin Sales, Value and Gross Margin (2019-2024)
8.11.4 Vazyme Biotech Procalcitonin Product Portfolio
8.11.5 Vazyme Biotech Recent Developments
8.12 Getein Biotech
8.12.1 Getein Biotech Comapny Information
8.12.2 Getein Biotech Business Overview
8.12.3 Getein Biotech Procalcitonin Sales, Value and Gross Margin (2019-2024)
8.12.4 Getein Biotech Procalcitonin Product Portfolio
8.12.5 Getein Biotech Recent Developments
8.13 Hotgen Biotech
8.13.1 Hotgen Biotech Comapny Information
8.13.2 Hotgen Biotech Business Overview
8.13.3 Hotgen Biotech Procalcitonin Sales, Value and Gross Margin (2019-2024)
8.13.4 Hotgen Biotech Procalcitonin Product Portfolio
8.13.5 Hotgen Biotech Recent Developments
8.14 Lumigenex
8.14.1 Lumigenex Comapny Information
8.14.2 Lumigenex Business Overview
8.14.3 Lumigenex Procalcitonin Sales, Value and Gross Margin (2019-2024)
8.14.4 Lumigenex Procalcitonin Product Portfolio
8.14.5 Lumigenex Recent Developments
8.15 Nanjing Norman Biological Technology
8.15.1 Nanjing Norman Biological Technology Comapny Information
8.15.2 Nanjing Norman Biological Technology Business Overview
8.15.3 Nanjing Norman Biological Technology Procalcitonin Sales, Value and Gross Margin (2019-2024)
8.15.4 Nanjing Norman Biological Technology Procalcitonin Product Portfolio
8.15.5 Nanjing Norman Biological Technology Recent Developments
8.16 Kitgen
8.16.1 Kitgen Comapny Information
8.16.2 Kitgen Business Overview
8.16.3 Kitgen Procalcitonin Sales, Value and Gross Margin (2019-2024)
8.16.4 Kitgen Procalcitonin Product Portfolio
8.16.5 Kitgen Recent Developments
8.17 Beijing KeyGen
8.17.1 Beijing KeyGen Comapny Information
8.17.2 Beijing KeyGen Business Overview
8.17.3 Beijing KeyGen Procalcitonin Sales, Value and Gross Margin (2019-2024)
8.17.4 Beijing KeyGen Procalcitonin Product Portfolio
8.17.5 Beijing KeyGen Recent Developments
8.18 Beijing Apis
8.18.1 Beijing Apis Comapny Information
8.18.2 Beijing Apis Business Overview
8.18.3 Beijing Apis Procalcitonin Sales, Value and Gross Margin (2019-2024)
8.18.4 Beijing Apis Procalcitonin Product Portfolio
8.18.5 Beijing Apis Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Procalcitonin Value Chain Analysis
9.1.1 Procalcitonin Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Procalcitonin Sales Mode & Process
9.2 Procalcitonin Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Procalcitonin Distributors
9.2.3 Procalcitonin Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings